---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-000551"
form_type: "8-K"
ticker: "BAX"
cik: "0000010456"
company_name: "BAXTER INTERNATIONAL INC"
filed_at: "2023-01-06T23:59:59+00:00"
generated_at: "2026-06-20T18:33:33.558356+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Baxter plans spinoff of Renal Care & Acute Therapies into public company; COO resigns

## Summary
- Spinoff of Renal Care and Acute Therapies into independent public company expected in 12-18 months; 2021 sales of those businesses ~$5B.
- Exploring strategic alternatives for BioPharma Solutions (BPS), including a potential sale or other separation.
- Simplifying operating model and manufacturing footprint; restructuring details to be provided on Feb 9, 2023 earnings call.
- COO Giuseppe Accogli resigned effective January 4, 2023; no longer an executive officer.
- New kidney care company would address ~$15B market with estimated 3-4% CAGR over next three years.

## SEC filing metadata
- accession: 0001628280-23-000551
- form_type: 8-K
- ticker: BAX
- cik: 0000010456
- company_name: BAXTER INTERNATIONAL INC
- filed_at: 2023-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10456/000162828023000551/0001628280-23-000551-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10456/000162828023000551/bax-20230104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-000551
- JSON: https://secwatch.observer/filing/0001628280-23-000551.json
- Plain text: https://secwatch.observer/filing/0001628280-23-000551.txt

## Key facts
- Executive change
  Giuseppe Accogli resigned as Executive Vice President and Chief Operating Officer at BAXTER INTERNATIONAL INC.
  - Action: resigned
  - Role: Executive Vice President and Chief Operating Officer
  source text: On January 4, 2023, Giuseppe Accogli, the Executive Vice President and Chief Operating Officer of Baxter International Inc. (“Baxter” or the “Company”), resigned as Executive Vice President and Chief Operating Officer of the Company effective immediately and no longer serves as an executive officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/10456/000162828023000551/0001628280-23-000551-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.